Abstract
Neutropenia in neonates is often associated with sepsis, prematurity and maternal hypertension with increased risk of mortality. We describe two neonates with neutropenia treated with granulocyte macrophage colony stimulating factor. The total and absolute neutrophil counts showed a marked response and led to a favourable outcome. Human granulocyte macrophage colony stimulating factor may be used as an adjuvant therapy for neonatal neutropenia of different aetiologies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Roberts RL, Szelc CM, Scates SMet al. Neutropenia in an extremely premature infant treated with recombinant human granulocyte colony stimulating factor.Am J Dis Child 1991; 146: 808–812.
Baley JE, Stork EK, Warkentin PI, Shurin SB. Buffy coat transfusions of neutropenic neonates with presumed sepsis: A prospective, randomized trial.Pediatrics 1987; 80:712–720.
Cairo MS, Worcester C, Rucker R, Bennets GA, Amlie R, Perkin Ret al. Role of circulating complement and polymorphonuclear leukocyte transfusion in treatment and outcome in critically ill neonates with sepsis.J Pediatr 1987; 110:935–941.
Cairo MS. Cytokines a new immunotherapy.Clin Perinatol 1991; 18:343–359.
Weite K, Bonilla MA, Gillio APet al. Recombinant human granutocyte colony stimulating factors. Effects on hematopoiesis in normal and cyclophosphamide treated primates.J Exp Med 1987; 165:941–948.
Bronchud MH, Scarffe JH, Thatcher Net al. Phase I/II study of recombinant human granulocyte colony stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer.Br J Cancer 1987; 56:809–813.
Steward WP. Granulocyte and granulocytemacrophage colony stimulating factors.Lancet 1993; 342:153–156.
Koenig JM, Christensen RD. Incidence, neutrophil kinetics and natural history of neonatal neutropenia associated with maternal hypertension.N Engl J Med 1989; 321:557–562.
Cairo MS, Mauss D, Kammareddy S, Norris K, Vande Ven C, Modanlon H. Prophylactic or simultaneous administration of recombinant human granulocyte colony stimulating factor in the treatment of group B streptococcal sepsis in neonatal rats.Pediatr Res 1990; 27:612–616.
Gillan ER, Christensen RD, Suen Y, Ellis R, Vande Ven C, Cairo MS. A randomized, placebo controlled trial of recombinant human granulocyte colony stimulating factor administration in newborn infants with presumed sepsis: Significant induction of peripheral and bone marrow neutrophiliaBlood 1994; 84: 1427–1433.
Dale DC. Potential role of colony stimulating factors in the prevention and treatment of infectious diseases.Clin Infect Dis 1994; 18: S 180–188.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ray, M., Mukhopadhyay, K. & Narang, A. Granulocyte macrophage-colony stimulating factor (GM-CSF) in neonatal neutropenia. Indian J Pediatr 67, 67–68 (2000). https://doi.org/10.1007/BF02802647
Issue Date:
DOI: https://doi.org/10.1007/BF02802647